Under the partnership, the contract research organisation (CRO) – which provides biometrics services, including clinical data management, statistical analysis and programming – will access Acceliant’s e-clinical data management services.
Acceliant’s services include drug supply management, medical coding, document management systems and electronic case report forms (eCRFs).
The agreement will contribute to Acceliant’s eCRFs, and allow for faster trial deployment in “all phases of clinical trials and BA/BE [bioavailability and bioequivalence services] studies” for Clinnex’s clients.
“We strongly believe that this partnership will help us speed up overall clinical trial timelines, in addition to adapting and address the ever changing challenges in clinical trials,” said Clinnex’s Jeenal Palan in a statement.
Acceliant also said it would benefit from the collaboration: “The addition of Clinnex’s comprehensive biometrics services will not only ensure 100% accuracy and integrity of clinical trial data across trial phases, but will also help us extend a seamless and superior experience to our clients,” said Acceliant’s Santhosh Nagaraj.